Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1987 Mar;77(3):351–353. doi: 10.2105/ajph.77.3.351

A comparison of estrogen and progesterone receptors in black and white breast cancer patients.

L N Beverly, W D Flanders, R C Go, S J Soong
PMCID: PMC1646891  PMID: 3812846

Abstract

After standardization for age and menopausal status, the prevalence of estrogen receptor positivity among 88 White breast cancer patients was about .72 compared with a prevalence of about .54 among Black patients. The prevalence of progesterone receptor positivity was also higher among White than among Black patients, although the magnitude of the difference was smaller. These differences were unchanged after adjustment for tumor size and nodal and distant metastases in addition to age and menopausal status.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brooks J. L., Ryan J. A., Jr, Bauermeister D. E. Prognostic significance of hormone receptors in early recurrence of breast cancer. Am J Surg. 1983 May;145(5):599–603. doi: 10.1016/0002-9610(83)90101-0. [DOI] [PubMed] [Google Scholar]
  2. Clark G. M., McGuire W. L., Hubay C. A., Pearson O. H., Marshall J. S. Progesterone receptors as a prognostic factor in Stage II breast cancer. N Engl J Med. 1983 Dec 1;309(22):1343–1347. doi: 10.1056/nejm198312013092240. [DOI] [PubMed] [Google Scholar]
  3. Dennis C. R., Gardner B., Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer. 1975 Mar;35(3):714–720. doi: 10.1002/1097-0142(197503)35:3<714::aid-cncr2820350326>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  4. Gregorio D. I., Cummings K. M., Michalek A. Delay, stage of disease, and survival among White and Black women with breast cancer. Am J Public Health. 1983 May;73(5):590–593. doi: 10.2105/ajph.73.5.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hulka B. S., Chambless L. E., Wilkinson W. E., Deubner D. C., McCarty K. S., Sr, McCarty K. S., Jr Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol. 1984 May;119(5):692–704. doi: 10.1093/oxfordjournals.aje.a113790. [DOI] [PubMed] [Google Scholar]
  6. Hähnel R., Woodings T., Vivian A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer. 1979 Aug;44(2):671–675. doi: 10.1002/1097-0142(197908)44:2<671::aid-cncr2820440238>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  7. McGuire W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol. 1978 Dec;5(4):428–433. [PubMed] [Google Scholar]
  8. Mohla S., Enterline J. P., Sampson C. C., Khan T., Leffall L., Jr, White J. E. A predominance of poorly differentiated tumors among black breast cancer patients: management and screening implications. Prog Clin Biol Res. 1982;83:249–258. [PubMed] [Google Scholar]
  9. Nemoto T., Vana J., Natarajan N., Bedwani R., Mettlin C. Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes and II. Estrogen receptor assay in the U.S. in 1977. Int Adv Surg Oncol. 1981;4:209–239. [PubMed] [Google Scholar]
  10. Qazi R., Chuang J. L., Drobyski W. Estrogen receptors and the pattern of relapse in breast cancer. Arch Intern Med. 1984 Dec;144(12):2365–2367. [PubMed] [Google Scholar]
  11. Silverberg E. Cancer statistics, 1985. CA Cancer J Clin. 1985 Jan-Feb;35(1):19–35. doi: 10.3322/canjclin.35.1.19. [DOI] [PubMed] [Google Scholar]
  12. Wilcosky T. C., Chambless L. E. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis. 1985;38(10):849–856. doi: 10.1016/0021-9681(85)90109-2. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES